Neogen Chemicals earnings calls.

Neogen Chemicals reported Q3 FY26 revenue of 220 croreCurrent reported value: 220 crore. No comparable prior figure is available in the source record. (9Current 9 crore vs previous available quarter 4 crore.% YoY) with EBITDA at 32 croreCurrent 32 crore vs previous available quarter 31.5 crore. and PAT of 4 croreCurrent 4 crore vs previous available quarter 10 crore., pressured by transient headwinds. Gross profit grew 13% YoYCurrent reported value: 13% YoY. No comparable prior figure is available in the source record. with ~150bps margin expansion, but EBITDA was impacted by Neoen Ionics ramp-up costs, Dahej fire incident toll manufacturing expenses, and higher finance costs from plant reconstruction. Insurance claims received stood at 83.48 croreCurrent 83.48 crore. Reported change: 9M FY26. (9M FY26), with net claim receivable at 251.12 croreCurrent reported value: 251.12 crore. No comparable prior figure is available in the source record.. The strategic Indo-Japan JV with Morita (80:20 split, $20M investment) for LiPF6 salt production is progressing, integrating Japanese technology for non-China-compliant supply chains. The Patanjali greenfield project remains on track for H1 FY27 (electrolyte) and H2 FY27 (salt) commercialization, synchronized with India's ACC battery rollout. 400-500 crore battery chemicals revenue guidance for FY27Current reported value: 400-500 crore battery chemicals revenue guidance for FY27. No comparable prior figure is available in the source record. is maintained. Risks include customer approval delays beyond June for Dahej site audits, working capital deterioration (higher inventory/receivables), and dependency on successful Patanjali commissioning.